Stylus Research Identifies Five Trends to Watch in the Legal #Cannabis Era
"What is most surprising about the cannabis market is the disconnect between the new reality and enduring misconceptions around who's using it and why." Marian Berelowitz, US senior editor at Stylus
New York - June 19, 2018 (Investorideas.com Newswire) The legal cannabis era is here. As the 'green rush' to capitalize on it builds momentum in North America, innovation research and advisory company Stylus highlights five emerging trends shaping the future of cannabis culture and consumption.
1. Cannabis Versus Cocktails
Cannabis has the potential to match alcohol as the recreational product of choice in the US. Use among US college students is already climbing, while drinking is declining. It plays a similar role to alcohol, lending itself to party-goers, parents and others looking to unwind – even serving as a host gift in lieu of wine. It's especially appealing to those eager to avoid hangovers or alcohol's calorie count.
2. 'Canna-Curious' Hubs
Commercialized cannabis is maturing into an opportunity expected to be worth $57bn globally by 2027, according to Arcview Group. Catering to an influx of newly intrigued consumers, brands are demystifying cannabis via strategies such as subscription boxes, cannabis socials for product sampling, and even Tinder-like apps. The next stage in educating consumers and cultivating fans will be cannabis tourism. California-based Flow Kana is turning a defunct winery into an experience center that will offer educational tours of its cannabis farm, along with tastings.
3. Female Focus
A 'by and for' women's sector is booming in the industry. Women are among the fastest-growing cohorts of cannabis consumers – spending by females on cannabis deliver app Eaze increased by 20% in 2017, and increasingly prolific as cannabis entrepreneurs. As a result, products that skew towards feminine tastes – from menstrual-relief products to sleek pipes and jewelry that doubles as a sophisticated roach clip – are proliferating. Women are defining the future of cannabis.
4. Medical-Grade Marijuana
Cannabis hasn't yet been widely integrated into the mainstream medical community, but that will change. We'll see an upswing in education available for healthcare providers and patients, and an evolution of products geared to patient use – enabling users to more precisely control dosing, for instance. Legalization is bringing more biotech and other start-ups into the space, all likely to advance understanding of how cannabis can aid patients and help adapt it to clinical use.
5. New Pet Essential
As several key medical benefits of cannabidiol (CBD, the non-psychoactive compound of cannabis) – including relief from anxiety and joint pain – appear to help animals as much as humans, CBD-infused products for pets are booming. The potential here is enormous, given that Americans now spend nearly $70bn annually on their pets, and younger owners in particular are embracing alternative remedies to ensure optimal animal health.
Stylus is a global innovation research and advisory company that identifies and connects the most important global and cross-industry trends. Our insights are used by more than 500 of the world's leading consumer brands, businesses and agencies to understand the attitudes and behaviors of their consumers, the products and services they're using, and how they engage with the world around them. Our team of 150 industry experts work across five continents, analyzing more than 20 consumer-facing industries. We operate out of New York, Miami, London, São Paulo, Melbourne, Singapore, Tokyo and South Korea. www.stylus.com.
PR Manager, Stylus
London, USA, Australia, Brazil, Japan, Singapore, Korea
T +44 20 3892 7544 | +44 7446 082106 | @Tasha_Fish
Marijuana / Hemp Stocks
At Cannabisinvestorideas.com and Investorideas.com
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.